Informations générales (source: ClinicalTrials.gov)
Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
Observational [Patient Registry]
Centre Leon Berard (Voir sur ClinicalTrials)
avril 2025
octobre 2027
02 mars 2026
MAGNETO is a French medico-economic study on preoperative localization in breast cancer
surgery. The main objective is to conduct a cost-consequence analysis comparing magnetic
clip localization with the use of metallic wires for the preoperative identification of
non-palpable breast lesions. The choice of localization method is left to the physician's
and center's discretion. The study is non-interventional (with only questionnaires and
data collection), prospective, and multicenter, with patient follow-up lasting up to six
months after breast surgery.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Angelica CONVERSANO | 23/07/2026 10:45:06 | Contacter | ||
| HOPITAL NOVO | VAUTIER-RIT Sophie | 18/09/2025 17:50:14 | Contacter | ||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Eugène Marquis - 35042 - Rennes - France | Susie BROUSSE, Dr | Contact (sur clinicalTrials) | |||
| Centre Léon Bérard - 69008 - Lyon - France | Marie OSDOIT, Dr | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Hôpital Nord -Ouest Val d'Oise (NOVO) - 95300 - Pontoise - France | Sophie VAUTIER-RIT, Dr | Contact (sur clinicalTrials) | |||
| Hospices Civils de Lyon Hopital de la Croix rousse - 69004 - Lyon - France | Marion CORTET, Dr | Contact (sur clinicalTrials) | |||
| Institut de Cancérologie de Lorraine (ICL) - 54519 - Nancy - France | David Manuel GOMES, Dr | Contact (sur clinicalTrials) | |||
| Institut GODINOT - 51726 - Reims - France | Judicaël HOTTON, Dr | Contact (sur clinicalTrials) | |||
Critères
Femme
- I1. Female aged ≥ 18 years;
- I2. Patient presenting with a unifocal and unilateral lesion of invasive carcinoma
or in situ;
- I3. Indication for first breast-conserving treatment with the need for preoperative
localization of the lesion, regardless of the associated lymph node procedure;
- I4. Patient affiliated with a health insurance system;
- I5. Non-opposition to the study.
Exclusion Criteria:
- E.1. Psychological, family, or sociological condition that may potentially
compromise adherence to the treatment protocol and follow-up;
- E.2. Bilateral surgery required;
- E.3. Patient with metastatic breast cancer;
- E.4. Multifocal or benign lesions;
- E.5. Pregnant or breastfeeding patient;
- E.6. Need for neoadjuvant treatment;
- E.8. Patient under guardianship, curatorship, or deprived of liberty.